Drug Trial Radar · NCT07913763
Rimonabant for Improving Walking Ability in Patients With Chronic Stroke
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Nov 30, 2026
Primary completion
Jan 31, 2028
Study completion Dec 31, 2028
Sponsor
- Lead sponsor
- Sinfatin S.LIndustry
- Sponsor type
- Industry
- First posted
- Nov 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The mail goal of this clinical trial is assess the effect of rimonabant in walking ability in people who experienced a stroke at least 12 months before enrollment. It will include 80 adults aged 18 to 75 years that will receive either rimonabant (5 mg) or placebo (a look-alike tablet that contains no drug) once daily for 90 days. Neither the participants nor the investigators will know which treatment is being given. The study will also help to learn about the safety of rimonabant.
Conditions
- Chronic Stroke
Interventions
RimonabantDrug
Rimonabant 5 mg administered orally as one orally disintegrating tablet (ODT) once daily for 90 consecutive days.
PlaceboDrug
Participants will receive one matching placebo orally disintegrating tablet (ODT) once daily for 90 consecutive days. The placebo contains no rimonabant.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Six-Minute Walk Test (6MWT)Time frame: Baseline to end of follow-up (day 135)
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Hospital Universitario de Albacete
Albacete, Albacete, Spain
Institut Guttmann
Badalona, Barcelona, Spain
Jiménez Lucena S.L. (CLÍNICA I+TÚ)
Córdoba, Córdoba, Spain
Hospital Los Madroños
Brunete, Madrid, Spain
Hospital Clínico San Carlos (HCSC)
Madrid, Madrid, Spain
Hospital Universitario La Paz
Madrid, Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.